These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26465326)

  • 1. Deletion of IL-18 Expression Ameliorates Spontaneous Kidney Failure in MRLlpr Mice.
    Schirmer B; Wedekind D; Glage S; Neumann D
    PLoS One; 2015; 10(10):e0140173. PubMed ID: 26465326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease.
    Bossù P; Neumann D; Del Giudice E; Ciaramella A; Gloaguen I; Fantuzzi G; Dinarello CA; Di Carlo E; Musiani P; Meroni PL; Caselli G; Ruggiero P; Boraschi D
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14181-6. PubMed ID: 14615579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic view of systemic autoimmunity in MRLlpr mice.
    Liu J; Karypis G; Hippen KL; Vegoe AL; Ruiz P; Gilkeson GS; Behrens TW
    Genes Immun; 2006 Mar; 7(2):156-68. PubMed ID: 16508641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPS-evoked IL-18 expression in mesangial cells plays a role in accelerating lupus nephritis.
    Shui HA; Ka SM; Wu WM; Lin YF; Hou YC; Su LC; Chen A
    Rheumatology (Oxford); 2007 Aug; 46(8):1277-84. PubMed ID: 17569745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crusted scabies in a child with systemic lupus erythematosus.
    Wanke NC; Melo C; Balassiano V
    Rev Soc Bras Med Trop; 1992; 25(1):73-5. PubMed ID: 1308069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
    Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
    J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus.
    Tsokos GC
    N Engl J Med; 2011 Dec; 365(22):2110-21. PubMed ID: 22129255
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
    Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
    Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
    Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis.
    Hammad A; Mosaad YM; Hammad EM; Elhanbly S; El-Bassiony SR; Al-Harrass MF; Eid R; Sharaf Eldein OA; Alsawah GA; Yahia S; Fawzy IM
    Autoimmunity; 2016; 49(1):31-40. PubMed ID: 26515887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17-producing T cells in lupus nephritis.
    Apostolidis SA; Crispín JC; Tsokos GC
    Lupus; 2011 Feb; 20(2):120-4. PubMed ID: 21303828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells.
    Luzina IG; Knitzer RH; Atamas SP; Gause WC; Papadimitriou JC; Sztein MB; Storrer CE; Handwerger BS
    Arthritis Rheum; 1999 Mar; 42(3):561-8. PubMed ID: 10088780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation.
    Tsai PY; Ka SM; Chang JM; Chen HC; Shui HA; Li CY; Hua KF; Chang WL; Huang JJ; Yang SS; Chen A
    Free Radic Biol Med; 2011 Aug; 51(3):744-54. PubMed ID: 21641991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
    Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
    J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.